Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)

Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)

A $4.3 million to $6.3 million gap between Integra's preliminary third-quarter revenue and the Wall Street estimate sent IART shares lower. SueWallSt notifies investors of a pending investigation into potential securities claims for shareholders who lost money.

Integra LifeSciences (NASDAQ: IART) Slashes Full-Year 2026 Guidance After Cincinnati Flood Disrupts Manufacturing

Integra LifeSciences Holdings Corp. (NASDAQ: IART) has cut its full-year 2026 earnings and revenue guidance after July flooding caused significant damage to its Cincinnati manufacturing facility. The company released preliminary unaudited third-quarter results, citing revised assumptions tied to the flooding event and updated projections for the broader business through year-end. Integra now expects full-year 2026 […]

Integra LifeSciences plunges 21% on preliminary Q3 results (IART:NASDAQ)

Integra LifeSciences (IART) stock plunges 21% after preliminary Q3 results, lowered EPS guidance, and a $600M refinancing plan.

Integra LifeSciences (NASDAQ:IART) Releases FY 2026 Earnings Guidance

Integra LifeSciences (NASDAQ:IART) updated its FY 2026 earnings guidance. The company provided EPS guidance of 2.300-2.400 for the period, compared to the consensus estimate of 2.460.

Integra Shares Plunge as Investor Probe Opens

PRINCETON, NJ – October 3, 2026 (STL.News) Integra LifeSciences Holdings Corp. shares plunged more than 21% Friday after the medical technology company lowered its 2026 financial outlook and revealed that flooding at its Cincinnati manufacturing facility is having a substantially larger and longer-lasting impact than previously anticipated. The selloff quickly attracted attention from securities attorneys, with Levi & Korsinsky LLP announcing an…